About us
Who we are
Governance
Staff
Vacancies
What we do
Members
EuropaBio Members
About Membership
How we work
Healthcare Biotechnology Council
Impact of the EU’s General Pharmaceutical Legislation on Europe’s innovation ecosystem and biotechnology companies
Patient BioForum
Industrial Biotechnology Council
Food, Feed & Nutrition
Circular Bioeconomy
National Associations Council
SME Platform
Biomanufacturing Platform
Activities
25 Years of Innovation
European Biotech Week
EFIB
News & Events
News
Events
Library
Become a member
✕
05/11/2021
It’s Coming…
12/08/2021
2006: Revolution in HIV treatment. First EMA approval for single tablet regimen taken once a day
02/07/2021
2019: Large scale microbial production of next generation, zero-calorie, non-artificial EVERSWEET™ Stevia sweetener
02/07/2021
1996: Understanding how the immune system recognises virus-infected cells. Nobel Prize for Physiology or Medicine
25/06/2021
Improved food safety through asparaginase produced via genetically modified micro-organisms: reduced acrylamide in cooked food
23/06/2021
It’s Coming…
18/06/2021
2017: First Radioligand therapy (RLT) approved in Europe for the treatment of gastroenteropancreatic neuroendocrine tumours – Lutathera®
18/06/2021
2014: First Industrial Fermentation-derived perfume ingredient Clearwood®
18/06/2021
2007: Landmark European publication behind ‘Knowledge Based Bioeconomy’ in Europe
18/06/2021
2007: First production of spider silk through biotechnology
18/06/2021
2003: Human Genome Project completion
18/06/2021
1996: First European Commission-approved product following European Agency for the Evaluation of Medicinal Products (EMEA, later EMA) recommendation
18/06/2021
2014: Checkpoint inhibitor innovation as key part of cancer immunotherapy
18/06/2021
2016: First curative gene therapy for ADA-SCID approved for infants
16/06/2021
1996: Introduction of law in Italy for early access to drugs (648/1996) to support rare disease patients
16/06/2021
2006: Globally accessible Gene Sequencing Technology
16/06/2021
1997: First clinical trial with D2E7 (Humira), the first fully human monoclonal antibody approved by the US Food and Drug Administration (FDA)
16/06/2021
1999: Messenger RNA (mRNA) patented in relation to therapeutic applications
16/06/2021
2000: Vitamin B2 shifts from chemical synthesis to exclusive biotechnological production in less than 15 years
16/06/2021
2001: First enzyme replacement therapy for to treat Fabry disease approved in the European Union, plus world’s largest database of Fabry disease patients
1
2
Next page
Become a member